Aclaris Therapeutics

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) is a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both aesthetic and medical, and immunology. Aclaris is focused on market segments with no FDA-approved medications or where treatment gaps exist.

 

Visit website